59 filings
Page 3 of 3
8-K
my1izpd5 85ga9qabooh
12 Aug 21
HOOKIPA Pharma Reports Second Quarter 2021 Financial Results and Recent Highlights
4:01pm
8-K
vf9a2 ekn7n
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
xw320
12 May 21
HOOKIPA Pharma Reports First Quarter 2021 Financial Results and Recent Highlights
7:21am
8-K
lc1 idrq4yybq3xv3zp
20 Apr 21
Departure of Directors or Certain Officers
12:00am
8-K
jv9ilu apd3p5jvgn
18 Mar 21
HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook
7:14am
8-K
79h32xq
11 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
z05atgjli hkgn
10 Dec 20
HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Preferred Stock
12:00am
8-K
et7yfggsgohj 3hlw2w
7 Dec 20
Regulation FD Disclosure
6:09am
8-K
o6r7ns
30 Nov 20
HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101
6:11am
8-K
d7ho2h
12 Nov 20
HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
7:38am
8-K
2hb8altnns1l0
19 Oct 20
Departure of Directors or Certain Officers
4:18pm
8-K
qmohmpfpxpryr
13 Aug 20
HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
7:23am
8-K
k7g38yb4vndr4x78
22 Jun 20
HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB-101
7:24am
8-K
0t2g ot8fxn
19 Jun 20
HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer
8:51am
8-K
nx60kdl4 8y
14 May 20
HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update
7:25am
8-K
s4982c6 glo4pvt987a
19 Mar 20
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update
7:06am
8-K
gkf9 ni7xv
12 Nov 19
HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update
4:04pm
8-K
1j07krcq898
12 Aug 19
HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights
4:06pm
8-K
rx4ujbyjc5ob 600b
23 Apr 19
Amendments to Articles of Incorporation or Bylaws
4:52pm